arrow
G

Giorgio Reggiardo

mediservice s.r.l.
H指数:23
被引数:1,906

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TAILORing ibrutinib dose and plasma levels in the real-life patient with Chronic Lymphocytic Leukemia.

在真实世界慢性淋巴细胞白血病患者中调整ibrutinib剂量和血浆水平

2026-09-210
PRE
Efficacy and Safety of the Extemporaneous Combination Nebivolol/Amlodipine in Patients with Hypertension Uncontrolled on Monotherapy: The BOTTICELLI Study

贝他洛尔/氨氯地平临时组合在单药治疗未控制的高血压患者中的疗效与安全性:BOTTICELLI研究

2026-07-310
OA
CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials

CONSORT-Children and Adolescents (CONSORT-C) 2026扩展声明:提升儿科随机试验的报告质量和影响力

2026-02-240
PRE
SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocols

SPIRIT-Children and Adolescents (SPIRIT-C) 2026扩展声明:增强儿科随机试验方案的报告和实用性

2026-02-240
PRE
SHORT-COURSE RADIOTHERAPY FOR OLDER PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER AND UNFIT FOR CHEMOTHERAPY: THE SOFT STUDY

短期放疗用于局部晚期直肠癌且不适合化疗的老年患者:SOFT研究

2025-10-250
PRE
A multicentre, prospective, randomized, open-label pragmatic trial to compare the effectiveness and safety of interferon beta-1a and glatiramer-acetate in paediatric patients affected by Multiple Sclerosis

一项多中心、前瞻性、随机、开放标签的实用试验,旨在比较干扰素β-1a和醋酸格列默在患有多发性硬化症的儿科患者中的有效性与安全性。

2025-08-080
OA